Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

X4 Pharmaceuticals (XFOR) Prepaid Assets (2018 - 2025)

X4 Pharmaceuticals' Prepaid Assets history spans 8 years, with the latest figure at $3.5 million for Q4 2025.

  • For Q4 2025, Prepaid Assets fell 36.88% year-over-year to $3.5 million; the TTM value through Dec 2025 reached $3.5 million, down 36.88%, while the annual FY2025 figure was $3.5 million, 36.88% down from the prior year.
  • Prepaid Assets reached $3.5 million in Q4 2025 per XFOR's latest filing, down from $4.9 million in the prior quarter.
  • In the past five years, Prepaid Assets ranged from a high of $7.3 million in Q4 2023 to a low of $3.5 million in Q4 2025.
  • Average Prepaid Assets over 5 years is $4.9 million, with a median of $5.0 million recorded in 2022.
  • Peak YoY movement for Prepaid Assets: skyrocketed 45.14% in 2021, then tumbled 36.88% in 2025.
  • A 5-year view of Prepaid Assets shows it stood at $5.3 million in 2021, then grew by 8.66% to $5.8 million in 2022, then increased by 25.68% to $7.3 million in 2023, then dropped by 23.43% to $5.6 million in 2024, then crashed by 36.88% to $3.5 million in 2025.
  • Per Business Quant, the three most recent readings for XFOR's Prepaid Assets are $3.5 million (Q4 2025), $4.9 million (Q3 2025), and $5.0 million (Q2 2025).